510(k) Report

510(k) · Cleared

Cleared

Xpert Xpress CoV-2/Flu plus

K263333510(k) SpecialCleared Oct 22, 202630-day reviewClass II21 CFR 866.3981

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cepheid® · QOF Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

Cleared on Oct 22, 2026 after a 30-day review. FDA has not posted a summary or statement for it, so its predicates are not known.

Decided
Oct 22, 2026
Review
30 days
Class
Class II
Product code
QOF
Recalls
None
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K263333Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QOF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QOF device

  1. #1 K241240 Panther Fusion SARS-CoV-2/Flu A/B/RSV Assayscore 17.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All QOF devices

QOF Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · QOF

13in 2025

2021: 12023: 72024: 92025: 132026 (partial year): 8
2007high 13 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QOF

178in 2025

2023: 238 days median2024: 147 days median2025: 178 days median2026 (partial year): 128 days median
2007high 238 (2023) · low 147 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QOF

2so far in 2026, the most since 2007

2023: 12024: 12025: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QOF

10in 2025

2023: 62024: 302025: 10
2007high 30 (2024) · low 0 (2007)2025

MAUDE reports naming product code QOF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
2023723816
20249147130
202513178110
202681282—
Cite this page

510(k) Report. “K263333: Xpert Xpress CoV-2/Flu plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K263333

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Nov 3, 2026
  • Page last updated Nov 3, 2026